# Biological E. to invest ₹1,800 crore in Hyderabad expansion

Biological E. announced an investment of ₹1,800 crore to expand manufacturing capacity at three facilities in Genome Valley, Hyderabad. The expansion will add 5 billion doses of vaccine capacity and create 2,518 jobs.

- Type: Expansion
- Announced: 2022-07-21
- Where: Genome Valley, Hyderabad, India
- Value: $226.0M (18.0B INR)
- Jobs: 2,518
- Status: announced
- Capacity: 5 billion doses per annum
- Products: vaccines, generic injectables, biological APIs

## Companies

- [Biological E. Limited](https://endata.com/companies/21997.md)

## Sources

- [thehindu.com](https://www.thehindu.com/news/national/telangana/biological-e-to-invest-1800-crore-in-hyderabads-genome-valley/article65666037.ece), 2022-07-21: "The investment will be focused on manufacturing of Janssen Covid vaccine, MR Vaccine, PCV Vaccine, Typhoid Vaccine, Covid Vaccine, Tetanus Toxide Ampoules, IPV Vaccine and Pertussis Vaccine, biological APIs and formulations, speciality generic injectables and R&D projects with a cumulative investmen"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.